Free Trial

TradeUP Acquisition (UPTDW) Competitors

$0.08 0.00 (0.00%)
As of 01/29/2025

UPTDW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ARDS, ACABW, BFRIW, and BTMDW

Should you be buying TradeUP Acquisition stock or one of its competitors? The main competitors of TradeUP Acquisition include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Aridis Pharmaceuticals (ARDS), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry.

TradeUP Acquisition vs.

180 Life Sciences (NASDAQ:ATNFW) and TradeUP Acquisition (NASDAQ:UPTDW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, dividends, community ranking, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk.

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
TradeUP Acquisition N/A N/A N/A

In the previous week, 180 Life Sciences had 1 more articles in the media than TradeUP Acquisition. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for TradeUP Acquisition. 180 Life Sciences' average media sentiment score of 1.89 beat TradeUP Acquisition's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Very Positive
TradeUP Acquisition Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
TradeUP AcquisitionN/AN/AN/AN/AN/A

180 Life Sciences and TradeUP Acquisition both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
TradeUP AcquisitionN/AN/A

Summary

180 Life Sciences beats TradeUP Acquisition on 2 of the 2 factors compared between the two stocks.

Get TradeUP Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for UPTDW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UPTDW vs. The Competition

MetricTradeUP AcquisitionBiological Products, Except Diagnostic Substances IndustryManufacturing SectorNASDAQ Exchange
Market CapN/AN/A$2.26B$9.14B
Dividend YieldN/AN/A2.59%3.98%
P/E RatioN/AN/A28.1417.66
Price / SalesN/AN/A152.6881.09
Price / CashN/AN/AN/A37.71
Price / BookN/AN/A2.154.73
Net IncomeN/AN/A$165.18M$225.42M
7 Day PerformanceN/AN/A0.59%-0.44%
1 Month PerformanceN/AN/A2.18%3.57%
1 Year PerformanceN/AN/A7.66%19.20%

TradeUP Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UPTDW
TradeUP Acquisition
N/A$0.08
flat
N/AN/A$0.00N/A0.003
ATNFW
180 Life Sciences
N/A$0.01
-1.1%
N/A+73.1%$0.00N/A0.007Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.03
flat
N/A-30.0%$0.00N/A0.002
AIMDW
Ainos
N/A$0.13
-23.5%
N/A+156.2%$0.00$40,633.000.0040
ALVOW
Alvotech
N/A$3.25
+2.8%
N/A-28.5%$0.00$391.87M0.004Short Interest ↓
Gap Up
High Trading Volume
ARAV
Aravive
N/A$0.04
flat
N/AN/A$0.00$9.14M0.0020High Trading Volume
ARDS
Aridis Pharmaceuticals
N/AN/AN/A-99.9%$0.00$3.09M0.0030
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.06
flat
N/A+39.1%$0.00N/A0.004
BFRIW
Biofrontera
N/A$0.08
flat
N/A+689.5%$0.00$35.36M0.0070
BTMDW
biote
N/A$0.51
flat
N/AN/A$0.00$193.06M0.00N/A

Related Companies and Tools


This page (NASDAQ:UPTDW) was last updated on 1/30/2025 by MarketBeat.com Staff
From Our Partners